4.3 Article

The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cell Biology

SPARC: a matricellular regulator of tumorigenesis

Shanna A. Arnold et al.

JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)

Article Medicine, General & Internal

Stromal Gene Signatures in Large-B-Cell Lymphomas

G. Lenz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Hematology

Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma

Gustaf Hedstrom et al.

BRITISH JOURNAL OF HAEMATOLOGY (2007)

Review Biochemistry & Molecular Biology

Rituximab therapy in malignant lymphoma

B. Coiffier

ONCOGENE (2007)

Article Pathology

CD163-A specific marker of macrophages in paraffin-embedded tissue samples

SK Lau et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)

Article Multidisciplinary Sciences

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

G Wright et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)